PatientsVille.com Logo

PatientsVille
Ipilimumab Side Effects

Report Ipilimumab Side Effects

If you experienced any harmful or unwanted effects of Ipilimumab, please share your experience. This could help to raise awareness about Ipilimumab side effects, identify uknown risks and inform health professionals and patients taking Ipilimumab.

Examples: headache, dizziness


The most commonly reported Ipilimumab side effects are:
Fatigue (8 reports)
Hip Pain (6 reports)
Itching (6 reports)
Neuropathy (6 reports)
Joint Pain (5 reports)
Cough (4 reports)
Neutropenia (4 reports)
Fever (3 reports)
Elevated Liver Enzymes (2 reports)
Headache (2 reports)
Retina (2 reports)
Skin (1 reports)

If you have experienced a side effect listed above, you can check a box to report it.


View a complete list of Ipilimumab side effects or compare Ipilimumab side effects

If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (eg, physician, pharmacist). Your health care provider can provide additional clinical information and complete a copy of the side effect reporting form.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

'

Ipilimumab Side Effects Reported to FDA

The following Ipilimumab reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Ipilimumab on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Colitis, Intestinal Perforation, Arthralgia, Gastrointestinal Stoma Complication
on Jan 07, 2014 Female from GB , 27 years of age, was diagnosed with and was treated with Ipilimumab. Directly after, patient experienced the unwanted or unexpected Ipilimumab side effects: colitis, intestinal perforation, arthralgia, gastrointestinal stoma complication. Ipilimumab dosage: Intp:26aug11.
Associated medications used:
  • Pizotifen (Tabs)
  • Sumatriptan (Tabs)
  • Paracetamol Tabs 500 Mg (Qds)
  • Prednisolone (Tabs 10 Mg)
  • Zopiclone
  • Ondansetron
  • Calceos (1 Df: 2 Unit Nos?tabs)
  • Cyclizine
Patient was hospitalized.

Gastroenteritis, Diarrhoea, Vomiting
Patient was taking Ipilimumab. Patient felt the following Ipilimumab side effects: gastroenteritis, diarrhoea, vomiting on Jan 07, 2014 from BE Additional patient health information: Female , 44 years of age, was diagnosed with and. Ipilimumab dosage: C4: 750 Mg?c5: 740 Mg.
Multiple prescriptions taken:
  • Cod Liver Oil (Capsules)
  • Vitamin B (Tablet)
  • Metrogel
  • Betamethasone
Patient was hospitalized.

Chest Pain
Adverse event was reported on Jan 07, 2014 by a Male taking Ipilimumab (Dosage: N/A) was diagnosed with and. Location: IN , 34 years of age, After Ipilimumab was administered, patient encountered several Ipilimumab side effects: chest pain. Patient was hospitalized.

Basedow^s Disease, Autoimmune Thyroiditis
on Jan 07, 2014 Female from BE , 24 years of age, was diagnosed with and was treated with Ipilimumab. Directly after, patient experienced the unwanted or unexpected Ipilimumab side effects: basedow^s disease, autoimmune thyroiditis. Ipilimumab dosage: N/A.


Interstitial Lung Disease
on Jan 07, 2014 Male from BE , 39 years of age, was diagnosed with and was treated with Ipilimumab. Patient felt the following Ipilimumab side effects: interstitial lung disease. Ipilimumab dosage: Interrupted On 10jun2012?total: 10000 Mg.
Multiple prescriptions taken:
  • Paracetamol


Deafness Unilateral
Patient was taking Ipilimumab. After Ipilimumab was administered, patient encountered several Ipilimumab side effects: deafness unilateral on Jan 07, 2014 from BE Additional patient health information: Male , 44 years of age, was diagnosed with and. Ipilimumab dosage: N/A.
Multiple concurrent drugs taken:
  • Citalopram (Tab)
  • Hydrocortisone (10mg Tab)
  • Multivitamin (Tab)
  • Simvastatin (Tab)
  • Synthroid
  • Testim
  • Vitamin D3 (Tab?1df:1000 Units)


Lymphadenopathy
Adverse event was reported on Jan 07, 2014 by a Male taking Ipilimumab (Dosage: N/A) was diagnosed with and. Location: FR , 54 years of age, Directly after, patient experienced the unwanted or unexpected Ipilimumab side effects: lymphadenopathy. Patient was hospitalized.

Sepsis, Septic Encephalopathy, Erysipelas
on Jan 07, 2014 Male from IN , 62 years of age, was diagnosed with and was treated with Ipilimumab. Patient felt the following Ipilimumab side effects: sepsis, septic encephalopathy, erysipelas. Ipilimumab dosage: N/A.
Multiple prescriptions taken:
  • Levothyrox
  • Hydrocortisone
  • Spiriva
  • Foradil
  • Androtardyl (1 Df=1 Injection)
Patient was hospitalized.

Hypersensitivity
on Jan 07, 2014 Female from IN , 45 years of age, was diagnosed with and was treated with Ipilimumab. After Ipilimumab was administered, patient encountered several Ipilimumab side effects: hypersensitivity. Ipilimumab dosage: Inter On 08apr11.
Multiple concurrent drugs taken:
  • Polaramine (08-09apr2011;9-19apr11 2mg/d)
  • Solu-medrol
Patient was hospitalized.

Endocarditis, Pericarditis
Patient was taking Ipilimumab. Directly after, patient experienced the unwanted or unexpected Ipilimumab side effects: endocarditis, pericarditis on Jan 07, 2014 from IN Additional patient health information: Male , 53 years of age, was diagnosed with and. Ipilimumab dosage: 1df=1250. Unit Not Specified.
Associated medications used:
  • Hydrocortisone
Patient was hospitalized.

C-reactive Protein Increased, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
Adverse event was reported on Jan 23, 2014 by a Female taking Ipilimumab (Dosage: N/A) was diagnosed with and. Location: JP , 29 years of age, weighting 89.95 lb, Patient felt the following Ipilimumab side effects: c-reactive protein increased, alanine aminotransferase increased, aspartate aminotransferase increased. Patient was hospitalized.

Diarrhoea, Hypokalaemia, Lipase Increased, Lymphocyte Count Decreased, Amylase Increased, Colitis
on Feb 04, 2014 Male from US , 37 years of age, weighting 192.9 lb, was diagnosed with and was treated with Ipilimumab. After Ipilimumab was administered, patient encountered several Ipilimumab side effects: diarrhoea, hypokalaemia, lipase increased, lymphocyte count decreased, amylase increased, colitis. Ipilimumab dosage: 10mg/kg,q3wks,lase Dose: 13nov13?3mg/kg.

Gastric Haemorrhage, Convulsion
on Jan 17, 2014 Male from US , weighting 186.5 lb, was diagnosed with and was treated with Ipilimumab. Directly after, patient experienced the unwanted or unexpected Ipilimumab side effects: gastric haemorrhage, convulsion. Ipilimumab dosage: Last Dose Given On: 09-dec-2013. Patient was hospitalized.

Ascites
Patient was taking Ipilimumab. Patient felt the following Ipilimumab side effects: ascites on Mar 19, 2014 from GB Additional patient health information: Male , 43 years of age, was diagnosed with and. Ipilimumab dosage: N/A. Patient was hospitalized.

Colitis, Diarrhoea, Hypophosphataemia
Adverse event was reported on Jan 22, 2014 by a Female taking Ipilimumab (Dosage: No Of Doses-4. 640 Mg Total?on 24,36,48+60?last Dose-25jul12; Removed From Protocol On 13aug12) was diagnosed with and. Location: US , 48 years of age, weighting 141.3 lb, After Ipilimumab was administered, patient encountered several Ipilimumab side effects: colitis, diarrhoea, hypophosphataemia. Patient was hospitalized.

Diarrhoea, Rash Maculo-papular, Colitis, Nausea, Vomiting, Lymphocyte Count Decreased
on Dec 30, 2013 Male from US , 53 years of age, weighting 249.1 lb, was diagnosed with and was treated with Ipilimumab. Directly after, patient experienced the unwanted or unexpected Ipilimumab side effects: diarrhoea, rash maculo-papular, colitis, nausea, vomiting, lymphocyte count decreased. Ipilimumab dosage: Last Dose:17dec2012?340mg. Patient was hospitalized.

Disorientation
on Feb 21, 2014 Female from US , 50 years of age, was diagnosed with and was treated with Ipilimumab. Patient felt the following Ipilimumab side effects: disorientation. Ipilimumab dosage: N/A. Patient was hospitalized.

Hypophosphataemia
Patient was taking Ipilimumab. After Ipilimumab was administered, patient encountered several Ipilimumab side effects: hypophosphataemia on Dec 26, 2013 from US Additional patient health information: Female , 28 years of age, weighting 145.5 lb, was diagnosed with and. Ipilimumab dosage: Over 90 Min, 4 Doses.?q 12 Weeks On Weeks 24, 36, 48 And 60?200 Mg, Last Dose On 22-jul-13..

Sepsis, Skin Infection, Lung Infection
Adverse event was reported on Dec 23, 2013 by a Female taking Ipilimumab (Dosage: 4 Dose) was diagnosed with and. Location: US , 46 years of age, weighting 271.2 lb, Directly after, patient experienced the unwanted or unexpected Ipilimumab side effects: sepsis, skin infection, lung infection.
Associated medications used:
  • Ascorbic Acid
  • Ferrous Sulfate
  • Hydralazine
  • Metoprolol (1-1/2 Pills)
Patient was hospitalized.

Convulsion, Diarrhoea, Asthenia, Acute Febrile Neutrophilic Dermatosis, Rash, Adrenal Insufficiency, Off Label Use
on Dec 22, 2013 Female from US , 59 years of age, was diagnosed with and was treated with Ipilimumab. Patient felt the following Ipilimumab side effects: convulsion, diarrhoea, asthenia, acute febrile neutrophilic dermatosis, rash, adrenal insufficiency, off label use. Ipilimumab dosage: 2 Doses.dose3 At 10 Mg/kg(oct-12)?dose4 At 3 Mg/kg (jun-13)?dose5 At 3 Mg/kg (jun-13)..
Multiple prescriptions taken:
  • Bevacizumab (Last On Oct-13.)
  • Temozolomide (50mg/m2)


Malignant Neoplasm Progression, Diarrhoea, Hyperglycaemia, Febrile Neutropenia, Colitis
on Mar 26, 2014 Male from GB , 69 years of age, was diagnosed with and was treated with Ipilimumab. After Ipilimumab was administered, patient encountered several Ipilimumab side effects: malignant neoplasm progression, diarrhoea, hyperglycaemia, febrile neutropenia, colitis. Ipilimumab dosage: 850 Mg Inj?most Recent Dose: 20sep2013.
Multiple concurrent drugs taken:
  • Carboplatin
  • Etoposide (9aug-22sep13-200mg-oral)
  • Topotecan
  • Simvastatin
  • Insulin (1df=20iu)
  • Omeprazole
  • Prednisolone
  • Fortisip (1df=3 Tabs)
Patient was hospitalized.


Patient was taking Ipilimumab. on Dec 16, 2013 from DE Additional patient health information: Male , 66 years of age, was diagnosed with and. Ipilimumab dosage: N/A.
Associated medications used:
  • Dtic


Hypokalaemia, Abdominal Pain, Colitis, Large Intestinal Haemorrhage, Diarrhoea, Nausea
Adverse event was reported on Dec 16, 2013 by a Female taking Ipilimumab (Dosage: Last Administered Date 12nov13 (total Dose 330mg)) was diagnosed with and. Location: US , 67 years of age, weighting 242.5 lb, Patient felt the following Ipilimumab side effects: hypokalaemia, abdominal pain, colitis, large intestinal haemorrhage, diarrhoea, nausea. Patient was hospitalized.

Colitis, Lipase Increased
on Dec 05, 2013 Female from US , 37 years of age, weighting 99.21 lb, was diagnosed with and was treated with Ipilimumab. After Ipilimumab was administered, patient encountered several Ipilimumab side effects: colitis, lipase increased. Ipilimumab dosage: Indu:q3 Weeks*4doses?main:q12 Weeks On Weeks 24,36,48,60?last Admin:17/1/13?totl Dose:135mg.

Colitis, Dyspnoea, Fatigue, Nausea
on Mar 20, 2014 Female from GB , 51 years of age, weighting 174.2 lb, was diagnosed with and was treated with Ipilimumab. Directly after, patient experienced the unwanted or unexpected Ipilimumab side effects: colitis, dyspnoea, fatigue, nausea. Ipilimumab dosage: Recent Dose :06nov13,27nov13.
Associated medications used:
  • Carboplatin (Recent Dose :06nov13)
  • Etoposide (Recent Dose :06nov13)
  • Metformin
  • Fluoxetine
  • Salbutamol
  • Beclomethasone
  • Cyclizine
  • Fluconazole
Patient was hospitalized.

  2 of 48 

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Ipilimumab Side Effects

    Did You Have a Ipilimumab Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Ipilimumab for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective